Life Science Pharmacy Recalls Hydroxocobalamin Injection Due to Penicillin Contamination
Life Science Pharmacy Inc. is recalling Hydroxocobalamin Injection due to potential penicillin cross-contamination. The recall covers all lot numbers and expiration dates distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves potential contamination with penicillin, a common allergen that can cause severe reactions, meeting the criteria for a Severe rating.
Plain-English summary
Life Science Pharmacy Inc. is recalling Hydroxocobalamin Injection, a prescription compounded product, due to potential cross-contamination with penicillin. The recall includes all lot numbers and all expiration dates of the product.
The product was distributed nationwide. The recall is classified as Class II by the U.S. Food and Drug Administration, indicating a situation that might cause temporary or medically reversible adverse health consequences.
Consumers and healthcare providers should stop using the recalled product and contact their pharmacist or physician for guidance on alternative treatments or returns.
The recalled product
- Product
- HYDROXOCOBALAMIN Injection, Rx, compounded by Life Science Pharmacy Inc., Harriman, NY
- Manufacturer
- Life Science Pharmacy Inc
- Category
- Drug — Compounded Injectable
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- all lot numbers
- all expiration dates
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 23 recalled by Life Science Pharmacy Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 23 products in this recall →Related recalls
Same manufacturer · Life Science Pharmacy Inc
See all →- HighLife Science Pharmacy Recalls Compounded Estriol Suppositories Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09
- SevereLife Science Pharmacy Recalls TRI-EST Lozenges Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09
- SevereLife Science Pharmacy Recalls HCG Injections Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09
- HighLife Science Pharmacy Recalls Compounded Estriol Vaginal Creams
FDA (Drugs) · 2015-12-09
- SevereLife Science Pharmacy Recalls Compounded Estriol Creams Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09
Same hazard · penicillin contamination
See all →- SevereGlaxoSmithKline Recalls Bactroban Nasal Ointment Due to Penicillin Contamination
FDA (Drugs) · 2016-07-27
- SevereGlaxoSmithKline Recalls Bactroban Cream Due to Penicillin Cross Contamination
FDA (Drugs) · 2016-07-27
- SevereGlaxoSmithKline Recalls Bactroban Cream Due to Penicillin Cross Contamination
FDA (Drugs) · 2016-07-27
- SevereLife Science Pharmacy Recalls BI-EST Capsules Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09
Similar recalls
- SevereHydroxocobalamin Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- Severe
- SevereAttix Pharmaceuticals Recalls Hydroxocobalamin Due to Penicillin Cross-Contamination Risk
FDA (Drugs) · 2015-04-29
- SevereNatures Pharmacy Recalls Hydroxocobalamin Injections Due to Sterility Concerns
FDA (Drugs) · 2014-03-12
- SevereAttix Pharmaceuticals Recalls Hydroxocobalamin HCl Due to Penicillin Cross-Contamination Risk
FDA (Drugs) · 2015-04-29
- SevereHydroxocobalamin Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23